Hambrecht & Quist Capital Management »

Seagen shares owned by Hambrecht & Quist Capital Management

Quarter-by-quarter ownership of Seagen shares owned by Hambrecht & Quist Capital Management from 13F filings

Historical chart of Hambrecht & Quist Capital Management investment in Seagen

Tip: Access up to 7 years of quarterly data

All positions including Seagen held by Hambrecht & Quist Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seagen by Hambrecht & Quist Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $22M 112k 192.46
2023-03-31 $46M 225k 202.47
2022-12-31 $14M 112k 128.51
2022-09-30 $7.3M 53k 136.83
2022-06-30 $35M 195k 176.94
2022-03-31 $48M 331k 144.05
2021-12-31 $62M 400k 154.60
2021-09-30 $35M 207k 169.80
2021-06-30 $33M 211k 157.88
2021-03-31 $31M 226k 138.86
2020-12-31 $51M 294k 175.14

More positions owned by Hambrecht & Quist Capital Management

Amgen Common (AMGN)
Johnson & Johnson Common (JNJ)
Gilead Sciences Common (GILD)
Regeneron Pharmaceuticals Common (REGN)
Vertex Pharmaceuticals Common (VRTX)
Eli Lilly and Company Common (LLY)
Unitedhealth Group Common (UNH)
Merck & Co Common (MRK)
AbbVie Common (ABBV)
Biogen Common (BIIB)
AstraZeneca Sponsored ADR (AZN)
Illumina Common (ILMN)
Abbott Laboratories Common (ABT)
Pfizer Common (PFE)
Thermo Fisher Scientific Common (TMO)

View all positions for Hambrecht & Quist Capital Management

Top funds holding Seagen

First City Capital Management
IFP Advisors
Spotlight Asset Group

View all funds holding Seagen